Femitraz 1mg Tablet

About

Femitraz 1mg Tablet contains Letrozole, an aromatase inhibitor. It works by selectively inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogens in various tissues, including breast tissue, fat, and muscle. In postmenopausal women, the primary source of estrogen is this peripheral conversion, as the ovaries no longer produce significant amounts. By blocking aromatase, Letrozole significantly reduces circulating estrogen levels.

This reduction in estrogen is crucial for treating hormone-receptor-positive breast cancer, as estrogen can stimulate the growth of these cancer cells. Femitraz is primarily used in postmenopausal women for adjuvant treatment of early breast cancer, extended adjuvant treatment after tamoxifen therapy, and first-line treatment of advanced breast cancer. Its action helps to slow or stop the growth of estrogen-dependent tumors.

Uses

• Adjuvant treatment of early hormone-receptor-positive breast cancer in postmenopausal women
• Extended adjuvant treatment of early breast cancer in postmenopausal women who have received prior tamoxifen therapy
• First-line treatment of hormone-receptor-positive advanced breast cancer in postmenopausal women
• Treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy

Directions For Use

Take this medicine orally, usually once daily, with or without food, as directed by your doctor. Swallow the tablet whole with a glass of water.

Benefits

• Effective in treating hormone-receptor-positive breast cancer
• Reduces the risk of cancer recurrence
• Can be used as first-line or extended adjuvant therapy
• Helps to shrink tumors in advanced disease
• Improves disease-free survival rates
• Generally well-tolerated with manageable side effects

Side Effects

• Hot flashes
• Joint pain (arthralgia)
• Fatigue
• Nausea
• Headache
• Dizziness
• Bone thinning (osteoporosis)
• Increased cholesterol levels
• Sweating
• Hair thinning
• Weight gain
• Peripheral edema

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may exacerbate hot flashes or other side effects.
• Pregnancy - Femitraz is contraindicated in pregnant women due to potential harm to the fetus. It is only for use in postmenopausal women.
• Breastfeeding - Femitraz is contraindicated in breastfeeding women. It is only for use in postmenopausal women.
• Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary. Liver function should be monitored.
• Kidney - No dose adjustment is typically required for mild to moderate renal impairment. Use with caution in severe renal impairment.
• Lung - No specific lung-related precautions are generally noted for Femitraz. However, any new or worsening respiratory symptoms should be reported to a doctor.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.